Biodegradable Drug Eluting Stents Market: By Material, By Application, By End-User and Geography 

download arrow download arrow Download Free Sample
settings arrow settings arrow email us

Biodegradable Drug Eluting Stents Market Size, Share, Growth, Trends, and Global Industry Analysis: By Material ( Metallic Alloy Stents, Polymeric Stents), By Application (Coronary Artery Disease, Peripheral Artery Disease), By End-User (Hospitals Cardiac Centers) and Region 

checked icon arrow_drop_down
checked icon Single User License $4400 $3520
checked icon Multiple User License $6600 $5280
checked icon Corporate User License $8900 $7120

Biodegradable Drug Eluting Stents Market size was valued at US$ 6.2 billion in 2023 and is poised to grow at a significant CAGR of 6.3% from 2024-2030. Drug-eluting stents are peripheral or coronary stents placed into narrowed peripheral or coronary arteries that slowly release the drug to block cell proliferation. Generally, these devices are made up of metal and remain permanently or removed through further surgery. Metal stents present drawbacks such as the predisposition to late stent thrombosis, impairment of imaging with multislice CT, hindrance of surgical revascularization. Biodegradable drug-eluting stents are made up of material that dissolves or absorbed in the body, these are temporary, and no need for further surgery to removal of the stent. These are also called as bioresorbable stents or naturally- dissolving stents.

Key Developments

  • On May 02 2024: Abbott, the global healthcare company, announced the launch of XIENCE Sierra™ Everolimus (drug) Eluting Coronary Stent System in India. XIENCE Sierra is one of the latest generation stents in the XIENCE™ family, now available to people suffering from blocked coronary arteries. For interventional cardiologists, it brings unparalleled safety to the most complex cases. This coronary stent offers an innovative design, advanced technology, and best-in-class deliverability. XIENCE Sierra demonstrates flexibility and precision, enabling physicians to access and unblock difficult-to-treat blockages
  • On May 13 2022: Medtronic plc , a global leader in healthcare technology, announced that it has received U.S. Food and Drug Administration (FDA) approval for the Onyx Frontier™ drug-eluting stent (DES). As the latest evolution in the Resolute DES family, Onyx Frontier DES leverages the same best-in-class stent platform as Resolute Onyx™ DES, with an enhanced delivery system1 designed to improve deliverability and increase acute performance2 in even the most challenging of cases
  • In October 2015, Boston Scientific Corporation received U.S. Food and Drug Administration (FDA) approval for the synergy bioabsorbable Polymer Drug-Eluting Stent System (BP-DES) for the treatment of coronary artery disease. Risk of complications in use and lower awareness about biodegradable stents among healthcare professionals in developing and developed regions are expected to hamper the growth of Biodegradable Drug Eluting Stents Market over the forecast period.

summary download arrow Download Free Sample

Global Biodegradable Drug Eluting Stents Market Summary

Study Period

2024-2030

Base Year

2023

CAGR

6.3%

Largest Market

North America

Fastest Growing Market

Asia Pacific

Biodegradable Drug Eluting Stents Market Dynamics

Biodegradable Drug growth is driven by growing prevalence of coronary artery diseases, increased geriatric population who are more prone to heart diseases. According to World Health Organization (WHO), cardiovascular diseases are a primary cause of deaths globally, an estimated 17.7 Mn people died from cardiovascular diseases in 2015, representing 31% of all global deaths. Of these deaths, an estimated 7.4 Mn were due to coronary heart disease and 6.7 million were due to heart stroke. Furthermore, biodegradable drug-eluting stents have various advantages over the traditional metal stents such as no need of further surgery to remove stent, quick restoration of blood flow and faster healing process which are expected to boost the biodegradable drug eluting stents market.

Global Biodegradable Drug Eluting Stents Market Segmentation Analysis

Report Benchmarks

Details

Report Study Period

2024-2030

Market Size in 2023

US$ 6.2 billion

Market CAGR

6.3%

By Type of Material

  • Metallic Alloy Stents
  • Polymeric Stents

By Application

  • Coronary Artery Disease
  • Peripheral Artery Disease

By End-user

  • Hospitals
  • Cardiac Centers

By Region

  • North America
  • Latin America
  • Europe
  • Asia Pacific
  • Middle East and Africa

Key Features of the Report

  • The biodegradable drug eluting stents market report provides granular level information about the market size, regional market share, historic market (2019-2023), and forecast (2024-2030)
  • The report covers in-detail insights about the competitor's overview, company share analysis, key market developments, and their key strategies
  • The report outlines drivers, restraints, unmet needs, and trends that are currently affecting the market
  • The report tracks recent innovations, key developments, and start-up details that are actively working in the market
  • The report provides a plethora of information about market entry strategies, regulatory framework, and reimbursement scenario
  • The report analyses the impact of the socio-political environment through PESTLE Analysis and competition through Porter's Five Force Analysis in addition to recent technology advancements and innovations in the market

Download Free Sample Report

I accept the Terms and Conditions,Disclaimers, GDPR Policy

Frequently Asked Questions

The biodegradable drug eluting stents market size was valued at US$ 6.2 billion in 2023.

The key segments covered in the biodegradable drug eluting stents market are technology, components, application, and end-users.

The Biodegradable drug eluting stents market key players Biosensors International Group (Singapore), Abbott Laboratories (U.S), Medtronic (U.S.), B. Braun Holding GmbH & Co. KG (B.Braun Melsungen) (Germany), Boston Scientific Corporation (U.S.), Terumo Corporation (Japan)

Author image

Author

Muni Kumar Meravath

Muni Kumar Meravath is a seasoned Healthcare Market Research Analyst with over 6 years of experience in the healthc.....

1.Executive Summary
2.Global Biodegradable Drug Eluting Stents Market Introduction 
2.1.Global Biodegradable Drug Eluting Stents Market  - Taxonomy
2.2.Global Biodegradable Drug Eluting Stents Market  - Definitions
2.2.1.Type of Material
2.2.2.Application
2.2.3.End-user
2.2.4.Region
3.Global Biodegradable Drug Eluting Stents Market Dynamics
3.1. Drivers
3.2. Restraints
3.3. Opportunities/Unmet Needs of the Market
3.4. Trends
3.5. Product Landscape
3.6. New Product Launches
3.7. Impact of COVID 19 on Market
4.Global Biodegradable Drug Eluting Stents Market Analysis, 2019 - 2023 and Forecast 2024 - 2030
4.1.  Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million)
4.2.  Year-Over-Year (Y-o-Y) Growth Analysis (%) 
4.3.  Market Opportunity Analysis 
5.Global Biodegradable Drug Eluting Stents Market  By Type of Material, 2019 - 2023 and Forecast 2024 - 2030 (Sales Value USD Million)
5.1. Metallic Alloy Stents
5.1.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million)
5.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
5.1.3. Market Opportunity Analysis 
5.2. Polymeric Stents
5.2.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million)
5.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
5.2.3. Market Opportunity Analysis 
6.Global Biodegradable Drug Eluting Stents Market  By Application, 2019 - 2023 and Forecast 2024 - 2030 (Sales Value USD Million)
6.1. Coronary Artery Disease
6.1.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million)
6.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
6.1.3. Market Opportunity Analysis 
6.2. Peripheral Artery Disease
6.2.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million)
6.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
6.2.3. Market Opportunity Analysis 
7.Global Biodegradable Drug Eluting Stents Market  By End-user, 2019 - 2023 and Forecast 2024 - 2030 (Sales Value USD Million)
7.1. Hospitals
7.1.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million)
7.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
7.1.3. Market Opportunity Analysis 
7.2. Cardiac Centers
7.2.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million)
7.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
7.2.3. Market Opportunity Analysis 
8.Global Biodegradable Drug Eluting Stents Market  By Region, 2019 - 2023 and Forecast 2024 - 2030 (Sales Value USD Million)
8.1. North America
8.1.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million)
8.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
8.1.3. Market Opportunity Analysis 
8.2. Europe
8.2.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million)
8.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
8.2.3. Market Opportunity Analysis 
8.3. Asia Pacific (APAC)
8.3.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million)
8.3.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
8.3.3. Market Opportunity Analysis 
8.4. Middle East and Africa (MEA)
8.4.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million)
8.4.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
8.4.3. Market Opportunity Analysis 
8.5. Latin America
8.5.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million)
8.5.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
8.5.3. Market Opportunity Analysis 
9.North America Biodegradable Drug Eluting Stents Market ,2019 - 2023 and Forecast 2024 - 2030 (Sales Value USD Million)
9.1. Type of Material Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
9.1.1.Metallic Alloy Stents
9.1.2.Polymeric Stents
9.2.  Application Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
9.2.1.Coronary Artery Disease
9.2.2.Peripheral Artery Disease
9.3.  End-user Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
9.3.1.Hospitals
9.3.2.Cardiac Centers
9.4.  Country Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
9.4.1.United States of America (USA)
9.4.2.Canada
10.Europe Biodegradable Drug Eluting Stents Market ,2019 - 2023 and Forecast 2024 - 2030 (Sales Value USD Million)
10.1. Type of Material Analysis  and Forecast  by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
10.1.1.Metallic Alloy Stents
10.1.2.Polymeric Stents
10.2.  Application Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
10.2.1.Coronary Artery Disease
10.2.2.Peripheral Artery Disease
10.3.  End-user Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
10.3.1.Hospitals
10.3.2.Cardiac Centers
10.4.  Country Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
10.4.1.Germany
10.4.2.France
10.4.3.Italy
10.4.4.United Kingdom (UK)
10.4.5.Spain
10.4.6.Rest of EU
11.Asia Pacific (APAC) Biodegradable Drug Eluting Stents Market ,2019 - 2023 and Forecast 2024 - 2030 (Sales Value USD Million)
11.1. Type of Material Analysis  and Forecast  by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
11.1.1.Metallic Alloy Stents
11.1.2.Polymeric Stents
11.2.  Application Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
11.2.1.Coronary Artery Disease
11.2.2.Peripheral Artery Disease
11.3.  End-user Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
11.3.1.Hospitals
11.3.2.Cardiac Centers
11.4.  Country Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
11.4.1.China
11.4.2.India
11.4.3.Australia and New Zealand (ANZ)
11.4.4.Japan
11.4.5.Rest of APAC
12.Middle East and Africa (MEA) Biodegradable Drug Eluting Stents Market ,2019 - 2023 and Forecast 2024 - 2030 (Sales Value USD Million)
12.1. Type of Material Analysis  and Forecast  by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
12.1.1.Metallic Alloy Stents
12.1.2.Polymeric Stents
12.2.  Application Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
12.2.1.Coronary Artery Disease
12.2.2.Peripheral Artery Disease
12.3.  End-user Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
12.3.1.Hospitals
12.3.2.Cardiac Centers
12.4.  Country Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
12.4.1.GCC Countries
12.4.2.South Africa
12.4.3.Rest of MEA
13.Latin America Biodegradable Drug Eluting Stents Market ,2019 - 2023 and Forecast 2024 - 2030 (Sales Value USD Million)
13.1. Type of Material Analysis  and Forecast  by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
13.1.1.Metallic Alloy Stents
13.1.2.Polymeric Stents
13.2.  Application Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
13.2.1.Coronary Artery Disease
13.2.2.Peripheral Artery Disease
13.3.  End-user Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
13.3.1.Hospitals
13.3.2.Cardiac Centers
13.4.  Country Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
13.4.1.Brazil
13.4.2.Mexico
13.4.3.Rest of LA
14. Competition Landscape
14.1.  Market Player Profiles (Introduction, Brand/Product Sales, Financial Analysis, Product Offerings, Key Developments, Collaborations, M & A, Strategies, and SWOT Analysis) 
14.2.1.Biosensors International Group (Singapore)
14.2.2.Abbott Laboratories (U.S)
14.2.3.Medtronic (U.S.)
14.2.4.B. Braun Holding GmbH & Co. KG (B.Braun Melsungen) (Germany)
14.2.5.Boston Scientific Corporation (U.S.)
14.2.6.Terumo Corporation (Japan)
15. Research Methodology 
16. Appendix and Abbreviations 

Key Market Players

  • Biosensors International Group (Singapore
  • Abbott Laboratories
  • Medtronic 
  • B. Braun Holding GmbH & Co. KG (B.Braun Melsungen) 
  • Boston Scientific Corporation 
  • Terumo Corporation 

Related Industry Reports

Chronic Refractory Gout Pharmaceuticals Market

Familial Mediterranean Fever Pharmaceuticals Market

Australia Point of Care Diagnostics Market

Aseptic Sampling Market